While Western countries have a higher prevalence of both types of IBD, there has been an increasing trend worldwide, including in Iran, in recent years ( 4 , 5 ), which imposes high-cost burdens on both the health system and the patients ( 6 - 8 ).
← all excerpts
All-cause mortality of hospitalized inflammatory bowel disease patients: a multicenter study from Iran.
1
—
—